title: [Hepatotoxicity of drugs commonly used in rheumatology].
authors.forename: R
authors.initials: R
authors.lastname: Abadia
authors.forename: P
authors.initials: P
authors.lastname: Jammet
authors.forename: B
authors.initials: B
authors.lastname: Christoforov
authors.forename: G A
authors.initials: GA
authors.lastname: Cremer
mesh_terms: D000082:Acetaminophen / Q000009:adverse effects; D000700:Analgesics / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000503:physiopathology; D011431:Dextropropoxyphene / Q000009:adverse effects; D005897:Glafenine / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007210:Indoleacetic Acids / Q000009:adverse effects; D010396:Penicillamine / Q000009:adverse effects; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012460:Sulfasalazine / Q000009:adverse effects
chemical_list: D000700:Analgesics; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D007210:Indoleacetic Acids; D000082:Acetaminophen; D012460:Sulfasalazine; D005897:Glafenine; D010396:Penicillamine; C017136:clometacin; D011431:Dextropropoxyphene
vernacular_title: Hépatotoxicité des médicaments couramment utilisés en rhumatologie.